Development and Validation of (18)F-FDG PET/CT-Based Multivariable Clinical Prediction Models for the Identification of Malignancy-Associated Hemophagocytic Lymphohistiocytosis

OBJECTIVE: (18)F-fluorodeoxyglucose (FDG) PET/CT is often used for detecting malignancy in patients with newly diagnosed hemophagocytic lymphohistiocytosis (HLH), with acceptable sensitivity but relatively low specificity. The aim of this study was to improve the diagnostic ability of (18)F-FDG PET/...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xu, Lu, Xia, Liu, Jun, Kan, Ying, Wang, Wei, Zhang, Shuxin, Liu, Lei, Li, Jixia, Yang, Jigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2022
Materias:
Nuclear Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961016/
https://www.ncbi.nlm.nih.gov/pubmed/35289150
http://dx.doi.org/10.3348/kjr.2021.0733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961016/
https://www.ncbi.nlm.nih.gov/pubmed/35289150
http://dx.doi.org/10.3348/kjr.2021.0733

Ejemplares similares